SU803: Pharmacology B

Study Board of Science

Teaching language: Danish or English depending on the teacher, but English if international students are enrolled
EKA: N810006112, N810006102
Censorship: Second examiner: None, Second examiner: External
Grading: Pass/Fail, 7-point grading scale
Offered in: Odense
Offered in: Autumn
Level: Master

STADS ID (UVA): N810006101
ECTS value: 5

Date of Approval: 25-03-2019

Duration: 1 semester

Version: Approved - active


29004401 (former UVA) is identical with this course description. 

Entry requirements

A bachelor degree in “biomedical sciences” (or the like).

Academic preconditions

Students taking the course are expected to have basic knowledge of molecular biology, biochemistry, physiology and neurobiology.

Course introduction

The aim of the course is to enable the student to understand rational pharmacotherapy and modern drug discovery.

The course builds on the knowledge acquired in the courses SU502: Medical Physiology and SU503: Pharmacology A, and refers to the courses SU802 and SU810. The course gives an academic basis for studying pharmacology in relationship to modern technology and health and apply this in future biomedical research.

In relation to the competence profile of the degree it is the explicit focus of the course to:
  • Give the competence to critically, summarise and present a pharmalogical topic
  • Give skills to design and interpret pharmacological research experiments
  • Give knowledge and understanding of the interrelationship between pathophysiological mechanisms and drug actions.

Expected learning outcome

The learning objectives of the course are that the student demonstrates the ability to:
  • understand and apply basic and novel mechanisms of action of drugs and their primary and secondary targets in relation to treatment and prevention of major diseases.
  • design experimental approaches and interpret experimental observations of pharmacological problems in particular and biomedical subjects in general.
  • apply pharmacological knowledge to e.g. cardiovascular, renal, pulmonary, malignant and central nervous system diseases and their drug treatment.
  • apply knowledge of risk factors to rational drug discovery, development and treatment.


The following main topics are contained in the course:
  • New techniques and modern molecular insights in drug receptors as main drug targets in relationship to acute and chronic drug treatment.
  • Relationships between pathophysiological mechanisms and drug discovery and applications.
  • Elaboration of specific examples of new classes of drugs for unmet needs and old drugs finding new applications in the cardiovascular, metabolic and central nervous systems.


Rang&Dale’s Pharmacology, 8th edition.
See Blackboard for syllabus lists and additional literature references.

Examination regulations

Prerequisite examination a)




Oral presentation




Second examiner: None




Full name and SDU username


Normally, the same as teaching language

Examination aids

To be announced during the course

ECTS value


Additional information

The prerequisite examination is a prerequisite for participation in exam element a)

Exam element a)




Type Prerequisite name Prerequisite course
Examination part Prerequisite examination a) N810006101, SU803: Pharmacology B


Written exam




Second examiner: External


7-point grading scale


Student Identification Card


Normally, the same as teaching language

Examination aids

No exam aids allowed. A closer description of the exam rules will be posted under 'Course Information' on Blackboard.

ECTS value


Additional information

The examination form for re-examination may be different from the exam form at the regular exam.
Reexamination in the same exam period or immediately thereafter.

Indicative number of lessons

45 hours per semester

Teaching Method

At the faculty of science, teaching is organized after the three-phase model ie. intro, training and study phase.

To strengthen social, scientific and experimental skills in relation to general and specific objectives of the course and stimulate integration of progressive knowledge (“red threat”) the course will make use of Problem Based Learning (PBL). PBL consists of small group work, with occasional supervision by instructors, comprising critical reading, problem definitions, protocol designs, experimentation (computer simulations), data analyses and interpretations, scientific presentation.

Activities during the study phase:
  • Study the textbook
  • Read, interpret, summarise, present and discuss scientific (pharmacological) review articles
  • Review old exam questions
  • Progressively understand the interrelationships between (i.e. integrate) the elements of the introduction and training phases
  • Repetition for the exam

Teacher responsible

Name E-mail Department
Ulrike Muscha Steckelings


Administrative Unit

Biokemi og Molekylær Biologi

Team at Registration & Legality


Recommended course of study